12 West Capital Management’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-115,341
Closed -$14.7M 16
2019
Q1
$14.7M Sell
115,341
-40,000
-26% -$5.07M 1.2% 11
2018
Q4
$19.4M Buy
155,341
+40,000
+35% +$6.84M 2% 11
2018
Q3
$25.6M Buy
+115,341
New +$23.4M 1.88% 13
2015
Q3
Sell
-306,830
Closed -$9.92M 19
2015
Q2
$9.92M Hold
306,830
1.13% 14
2015
Q1
$9.2M Hold
306,830
1.02% 14
2014
Q4
$10.3M Sell
306,830
-327,670
-52% -$10.2M 1.28% 13
2014
Q3
$20.8M Buy
+634,500
New +$19.5M 2.43% 14

Other funds holding MED

12 West Capital Management's MED Position: Q2 2019 in Review

12 West Capital Management sold out of Medifast (MED) in Q2 2019, closing a stake of 115,341 shares — an estimated $14.7M sold.

12 West Capital Management first reported a position in MED in Q3 2014 and held it in 7 quarters. The position peaked at $25.6M in Q3 2018. 251 funds tracked by Wall St. Rank hold MED as of Q2 2019.

  • 12 West Capital Management reported no remaining Medifast position as of Q2 2019 after selling out during the quarter.
  • 12 West Capital Management sold 115,341 Medifast shares in Q2 2019, an estimated $14.7M.
  • 12 West Capital Management first reported a position in Medifast in Q3 2014 and held it in 7 quarters.
  • 12 West Capital Management's Medifast position peaked at $25.6M in Q3 2018.
  • 251 funds tracked by Wall St. Rank held Medifast as of Q2 2019.

Based on 12 West Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.